Form 4: Humana Director Frank A. D'Amelio Reports Stock Transactions
SEC Form 4 Filing
Director Frank A. D'Amelio of Humana Inc. reports the acquisition of restricted stock units and the transfer of common stock into a grantor retained annuity trust.
Summary
- Frank A. D'Amelio, a director at Humana Inc., filed a Form 4 detailing changes in his beneficial ownership of company stock.
- The report includes the acquisition of 783 restricted stock units as part of his annual director's fee, which are deferred until his resignation.
- Additionally, 2,467 restricted stock units were acquired through the conversion of director's cash fees, also deferred until resignation.
- A further 318 restricted stock units were acquired through the reinvestment of dividends on vested and deferred stock units, also deferred until resignation.
- Mr. D'Amelio transferred 20,634 shares of Humana common stock into a new 2024 Grantor Retained Annuity Trust, where he serves as the sole trustee.
Sentiment
Score: 7
Explanation: The document reflects standard transactions for a company director, indicating a neutral to slightly positive sentiment due to the continued alignment of the director's interests with the company's performance.
Future Outlook
The restricted stock units will be payable in Humana Inc. common stock on a 1-for-1 basis upon Mr. D'Amelio's resignation as a director.
Industry Context
This filing is a routine disclosure of stock transactions by a company director, which is common practice in publicly traded companies.
Comparison to Industry Standards
- The use of restricted stock units as part of director compensation is a common practice among publicly traded companies, including those in the healthcare sector.
- Deferred compensation plans, such as the one described, are also frequently used to align the interests of directors with the long-term performance of the company.
- The transfer of shares into a grantor retained annuity trust is a common estate planning strategy used by high-net-worth individuals, including corporate directors.
Stakeholder Impact
- The transactions have a minimal direct impact on shareholders, as they primarily involve the director's personal holdings and compensation.
- The deferred nature of the stock units aligns the director's interests with the long-term performance of the company, which is generally positive for shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/29/2024 | Effective date of the transfer of 20,634 shares into a new 2024 Grantor Retained Annuity Trust. |
| 01/02/2025 | Date of the earliest transaction reported, including the acquisition of restricted stock units. |
| 01/03/2025 | Date of signature for the Form 4 filing. |
Keywords
Humana, Director, Stock Units, Restricted Stock, Grantor Retained Annuity Trust, Form 4, Beneficial Ownership, Deferred Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.